3 of the Best Stocks Under $100 to Buy in 2026

• These stocks each wage much than 3% successful dividends.

• They person humble valuations that look ungraded inexpensive erstwhile compared to the S&P 500.

• Their maturation prospects whitethorn besides beryllium amended than they look astatine archetypal glance.

• 10 stocks we similar amended than Novo Nordisk ›

Want immoderate good, inexpensive stocks to bargain for the caller year? The ones that I've listed beneath each commercialized beneath $100 a share, are inexpensive with respect to their earnings, and connection a premix of value, dividends, and growth.

Novo Nordisk (NYSE: NVO), Comcast (NASDAQ: CMCSA), and AT&T (NYSE: T) are 3 fantabulous stocks you tin adhd to your portfolio contiguous and bent connected to for not lone this year, but for the agelong haul. Here's wherefore these tin beryllium among the champion buys nether $100 close now.

The past twelvemonth was a pugnacious 1 for Novo Nordisk, arsenic its shares plunged 41% successful 2025. The healthcare institution has been facing immoderate challenging headwinds arsenic it changed CEOs and besides slashed its guidance. But I'm inactive optimistic connected the company's aboriginal and stay invested successful the business, due to the fact that I judge things volition get overmuch amended for Novo Nordisk, perchance successful the precise adjacent future.

The company, known for its fashionable diabetes cause Ozempic, launched its GLP-1 pill for obesity this month. It is an oral mentation of its injectable value nonaccomplishment drug, Wegovy. Not lone is it easier to instrumentality the value nonaccomplishment medication, it's besides cheaper successful pill signifier and easier to mass-produce.

Novo Nordisk inactive possesses a ton of maturation potential. Investors shouldn't beryllium discouraged by a guidance chopped past year, which was mostly owed to compounding pharmacies selling knock-off versions of its fashionable drugs. If regulators clamp down connected that and its value nonaccomplishment pill proves to beryllium the catalyst that it tin be, 2026 could beryllium a large comeback twelvemonth for this pharma stock.

Novo Nordisk banal trades astatine astir $55, and its guardant price-to-earnings (P/E) aggregate is lone 14, which is acold beneath the S&P 500 mean of 22. The banal besides pays a dividend yielding 3.3%, giving you plentifulness of inducement to bent connected to it for the agelong haul.

Media and amusement institution Comcast is an adjacent cheaper banal to own. It's trading astir $28 per share, and its guardant P/E aggregate is lone 7. This is simply a severely discounted banal that offers a precocious output of 4.5% and has a coagulated and divers concern that makes it a suitable semipermanent investment.

Comcast precocious spun disconnected Versant, which includes cablegram TV networks and different assets that Comcast didn't spot arsenic portion of its halfway maturation strategy. By making it leaner and much focused connected its streaming, taxable parks, broadband, and wireless businesses, this determination tin assistance amended Comcast's equilibrium expanse and fortify its maturation prospects successful the process.